Letter: Treatment of spasticity in multiple sclerosis with dantrolene.
D002986:Clinical Trials as Topic; D003620:Dantrolene / Q000627:therapeutic use*; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D010919:Placebos; D012964:Sodium / Q000627:therapeutic use; D013035:Spasm / Q000188:drug therapy*
D006827:Hydantoins; D010919:Placebos; D012964:Sodium; D003620:Dantrolene